newsfilter
← Latest News
GlobeNewswire·

Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company, today announced financial results for the first quarter ended